Review of Jubilant Cadista Pharmaceuticals Inc
Jubilant Cadista Pharmaceuticals Inc is a U.S. generic pharmaceutical drug company based in Noida, India. It was established in 2005 and is a subsidiary of Jubilant Life Sciences LTD, which is a pharmaceutical research company, based in India as well. The parent company is listed on the Indian Stock Exchange under the ticker symbol JOL: IN. Jubliant Cadista Pharmaceuticals Inc has its Food and Drug Administration (FDA) production facilities in Salisbury, Maryland for the drug products it markets for use in the United States. Another production facility is scheduled to open in Roorkee, India in 2011 due to the increased demand for its products.
The company is currently marketing 10 drug products generically in the United States with research continuing for more upcoming products. Current products in generic and brand names include: Cyclobenzaprine (Flexeril Tablets), Hydrochlorothiazide (Microzide, Hydrodiuril – Tablets and Capsules), Lamotrigine (Lamictal), Methylprednisolone (Medrol), Meclizine (Antivert), Oxcarbazepine (Trileptal), Prednisone (Deltasone), Prochlorperazine (Compazine), and Terazosin (Hytrin).
The Company maintains an impressive growth rate. In the year 2009 to 2010, the company’s sales increased by 45% according to U.S. Pharmacist Generic Drug Review magazine issued in June 2011. Majority of the management in the company are western education businessmen who had long years of prior experience working in management positions in respected industry giants such as Eli Lilly and Company, Johnson and Johnson, Bristol Myers Squibb, Mylan Pharmaceuticals, GlaxoSmithKline Co, Wyeth-Ayerst Laboratories, Inc. and many others. There are also members in the upper management positions who have already held job positions at the Food and Drug Administration (FDA). Even though Jubilant Cadista Pharmaceuticals Inc is listed as a Indian generic manufacturer reaching into the U.S. market through its production facility in Maryland, only three of its senior management positions are held by Indians while the other 10 positions are occupied by western educated and qualified former executives from aforementioned companies.
The company is continuing to expand with eight listed job openings and management positions available at its Salisbury, Maryland production facility. The current Chief Executive Office is Scott B. Delaney who has over 17 years of experience working in the Pharmaceutical industry. The listed address is 1155 Business Center Dr, Suite 220, Horsham, PA 19044. The customer service number for the company is 800-313-4623 and the email is Customer.Service@Cadista.com. Patients can call the company to get medication information and specific information on a drug product by calling 800-313-4623 (Press 4). You can also report all side effects, medication allergies and unintended effects or problems you encountered to the company by calling 800-308-3985. Reporting side effects will help ensure quality control at the company and prevent potentially harmful products from being marketed.
All generic drug companies are approved by the FDA before any products are allowed to be marketed in the United States. Generic products have comparable bioavailability, safety margins and effectiveness as the brand name product. The difference between the generic and brand name products are the inactive ingredients used in the formulation and product of the drug product as well as the companies that make the two products. The greatest difference, what patients really care about, is the price – generics are largely cheaper than the brand and just as effective. Jubilant Cadista Pharmaceuticals Inc is not any different. Its products are reviewed and approved by the FDA based on actual lab data and test results. So any concerns regarding which country the company is based in should not be a factor in deciding whether a medication is safe for you. Any further concerns can be addressed by your pharmacist – so stop by your local pharmacy and ask a question!